The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure.
Mucopolysaccharidosis (MPS) IIIB is a lysosomal disease due to the deficiency of the enzyme α-N-acetylglucosaminidase (NAGLU) required for heparan sulfate (HS) degradation. The disease is characterized by mild somatic features and severe neurological disorders. Very little is known on the cardiac dy...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4493027?pdf=render |
| _version_ | 1818479157923807232 |
|---|---|
| author | Gabriele Giacomo Schiattarella Giuliana Cerulo Valeria De Pasquale Pasquale Cocchiaro Orlando Paciello Luigi Avallone Maria Paola Belfiore Francesca Iacobellis Daniele Di Napoli Fabio Magliulo Cinzia Perrino Bruno Trimarco Giovanni Esposito Paola Di Natale Luigi Michele Pavone |
| author_facet | Gabriele Giacomo Schiattarella Giuliana Cerulo Valeria De Pasquale Pasquale Cocchiaro Orlando Paciello Luigi Avallone Maria Paola Belfiore Francesca Iacobellis Daniele Di Napoli Fabio Magliulo Cinzia Perrino Bruno Trimarco Giovanni Esposito Paola Di Natale Luigi Michele Pavone |
| author_sort | Gabriele Giacomo Schiattarella |
| collection | DOAJ |
| description | Mucopolysaccharidosis (MPS) IIIB is a lysosomal disease due to the deficiency of the enzyme α-N-acetylglucosaminidase (NAGLU) required for heparan sulfate (HS) degradation. The disease is characterized by mild somatic features and severe neurological disorders. Very little is known on the cardiac dysfunctions in MPS IIIB. In this study, we used the murine model of MPS IIIB (NAGLU knockout mice, NAGLU(-/-)) in order to investigate the cardiac involvement in the disease. Echocardiographic analysis showed a marked increase in left ventricular (LV) mass, reduced cardiac function and valvular defects in NAGLU(-/-) mice as compared to wild-type (WT) littermates. The NAGLU(-/-) mice exhibited a significant increase in aortic and mitral annulus dimension with a progressive elongation and thickening of anterior mitral valve leaflet. A severe mitral regurgitation with reduction in mitral inflow E-wave-to-A-wave ratio was observed in 32-week-old NAGLU(-/-) mice. Compared to WT mice, NAGLU(-/-) mice exhibited a significantly lower survival with increased mortality observed in particular after 25 weeks of age. Histopathological analysis revealed a significant increase of myocardial fiber vacuolization, accumulation of HS in the myocardial vacuoles, recruitment of inflammatory cells and collagen deposition within the myocardium, and an increase of LV fibrosis in NAGLU(-/-) mice compared to WT mice. Biochemical analysis of heart samples from affected mice showed increased expression levels of cardiac failure hallmarks such as calcium/calmodulin-dependent protein kinase II, connexin43, α-smooth muscle actin, α-actinin, atrial and brain natriuretic peptides, and myosin heavy polypeptide 7. Furthermore, heart samples from NAGLU(-/-) mice showed enhanced expression of the lysosome-associated membrane protein-2 (LAMP2), and the autophagic markers Beclin1 and LC3 isoform II (LC3-II). Overall, our findings demonstrate that NAGLU(-/-) mice develop heart disease, valvular abnormalities and cardiac failure associated with an impaired lysosomal autophagic flux. |
| first_indexed | 2024-12-10T09:57:05Z |
| format | Article |
| id | doaj.art-8f6c35909da24e70ac0a8ddd8e751900 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-10T09:57:05Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-8f6c35909da24e70ac0a8ddd8e7519002022-12-22T01:53:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013166210.1371/journal.pone.0131662The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure.Gabriele Giacomo SchiattarellaGiuliana CeruloValeria De PasqualePasquale CocchiaroOrlando PacielloLuigi AvalloneMaria Paola BelfioreFrancesca IacobellisDaniele Di NapoliFabio MagliuloCinzia PerrinoBruno TrimarcoGiovanni EspositoPaola Di NataleLuigi Michele PavoneMucopolysaccharidosis (MPS) IIIB is a lysosomal disease due to the deficiency of the enzyme α-N-acetylglucosaminidase (NAGLU) required for heparan sulfate (HS) degradation. The disease is characterized by mild somatic features and severe neurological disorders. Very little is known on the cardiac dysfunctions in MPS IIIB. In this study, we used the murine model of MPS IIIB (NAGLU knockout mice, NAGLU(-/-)) in order to investigate the cardiac involvement in the disease. Echocardiographic analysis showed a marked increase in left ventricular (LV) mass, reduced cardiac function and valvular defects in NAGLU(-/-) mice as compared to wild-type (WT) littermates. The NAGLU(-/-) mice exhibited a significant increase in aortic and mitral annulus dimension with a progressive elongation and thickening of anterior mitral valve leaflet. A severe mitral regurgitation with reduction in mitral inflow E-wave-to-A-wave ratio was observed in 32-week-old NAGLU(-/-) mice. Compared to WT mice, NAGLU(-/-) mice exhibited a significantly lower survival with increased mortality observed in particular after 25 weeks of age. Histopathological analysis revealed a significant increase of myocardial fiber vacuolization, accumulation of HS in the myocardial vacuoles, recruitment of inflammatory cells and collagen deposition within the myocardium, and an increase of LV fibrosis in NAGLU(-/-) mice compared to WT mice. Biochemical analysis of heart samples from affected mice showed increased expression levels of cardiac failure hallmarks such as calcium/calmodulin-dependent protein kinase II, connexin43, α-smooth muscle actin, α-actinin, atrial and brain natriuretic peptides, and myosin heavy polypeptide 7. Furthermore, heart samples from NAGLU(-/-) mice showed enhanced expression of the lysosome-associated membrane protein-2 (LAMP2), and the autophagic markers Beclin1 and LC3 isoform II (LC3-II). Overall, our findings demonstrate that NAGLU(-/-) mice develop heart disease, valvular abnormalities and cardiac failure associated with an impaired lysosomal autophagic flux.http://europepmc.org/articles/PMC4493027?pdf=render |
| spellingShingle | Gabriele Giacomo Schiattarella Giuliana Cerulo Valeria De Pasquale Pasquale Cocchiaro Orlando Paciello Luigi Avallone Maria Paola Belfiore Francesca Iacobellis Daniele Di Napoli Fabio Magliulo Cinzia Perrino Bruno Trimarco Giovanni Esposito Paola Di Natale Luigi Michele Pavone The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure. PLoS ONE |
| title | The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure. |
| title_full | The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure. |
| title_fullStr | The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure. |
| title_full_unstemmed | The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure. |
| title_short | The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure. |
| title_sort | murine model of mucopolysaccharidosis iiib develops cardiopathies over time leading to heart failure |
| url | http://europepmc.org/articles/PMC4493027?pdf=render |
| work_keys_str_mv | AT gabrielegiacomoschiattarella themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT giulianacerulo themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT valeriadepasquale themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT pasqualecocchiaro themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT orlandopaciello themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT luigiavallone themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT mariapaolabelfiore themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT francescaiacobellis themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT danieledinapoli themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT fabiomagliulo themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT cinziaperrino themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT brunotrimarco themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT giovanniesposito themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT paoladinatale themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT luigimichelepavone themurinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT gabrielegiacomoschiattarella murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT giulianacerulo murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT valeriadepasquale murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT pasqualecocchiaro murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT orlandopaciello murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT luigiavallone murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT mariapaolabelfiore murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT francescaiacobellis murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT danieledinapoli murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT fabiomagliulo murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT cinziaperrino murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT brunotrimarco murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT giovanniesposito murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT paoladinatale murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure AT luigimichelepavone murinemodelofmucopolysaccharidosisiiibdevelopscardiopathiesovertimeleadingtoheartfailure |